Functionalization of bacterial cellulose with antibiotics for use as awound dressing
DOI:
https://doi.org/10.31989/bchd.v8i9.1735Abstract
Background: Presently, bacterial cellulose (BC) represents a promising biomaterial for biomedical applications, due to its exceptional properties. The capacity of BC to absorb and retain water, facilitating gas exchange, as well as its ability to serve as a scaffold for antimicrobial agents, makes it an optimal material for wound dressing that promotes healing and prevents infection.
Objective: The objective of the research was to obtain and study BC composites containing antibiotics with controlled release and significant antibacterial activity for potential use as wound dressings.
Methods: BC films were obtained by static co-fermentation of Komagataeibacter xylinus MS2530 strains with Pichia fermentans MDC 10169 on brewing waste (brewer’s spent yeast (BSY)). The preparation of BC/antibiotic composites was achieved by immersing dry films in ceftriaxone and tetracycline solutions for 24 h in a sterile environment. The composites' morphology was analyzed by Fourier-transform infrared spectroscopy (FTIR) to evaluate their chemical structure and compatibility with ceftriaxone and tetracycline. The loading efficiency and release profile of ceftriaxone and tetracycline antibiotics were evaluated using a spectrophotometric method. The antimicrobial activity of BC composites was determined using test cultures Еscherichia coli and Staphylococcus aureus.
Results: The process of co-fermentation using the BSY medium made it possible to produce BC films at a low cost. Based on BC films, BC/antibiotic composites with controlled release and significant antibacterial activity were obtained, which is a novelty of this study.
Conclusion: The co-fermentation of K. xylinus MS2530 and P. fermentans MDC 10169 on BSY medium simultaneously increase the BC yield and reduce fermentation time, leading to a substantial reduction in production costs. BC composites obtained by modifying BC films with antibiotics, exhibit significant antibacterial activity against E. coli and S. aureus. Therefore, the BC composites obtained have a possible potential for application as dressings for wound surface treatment.
Keywords: BC composite, tetracycline, ceftriaxone, controlled release, alternative wound dressing
Downloads
Published
Issue
Section
License
Copyright (c) 2025 FFC/Bioactive Compounds in Health and Disease
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.